User contributions for Noxoug1
A user with 1,407 edits. Account created on 26 February 2019.
16 July 2024
- 07:4307:43, 16 July 2024 diff hist +17 GSK plc →Recent developments Tag: Visual edit
- 07:4007:40, 16 July 2024 diff hist +352 GSK plc →Recent developments Tag: Visual edit
- 07:3407:34, 16 July 2024 diff hist +1 GSK plc →2000: Glaxo Wellcome and SmithKline Beecham merger Tag: Visual edit
2 July 2024
- 11:2311:23, 2 July 2024 diff hist +1,685 Amivantamab →Legal status: nsclc in EU Tag: Visual edit
- 11:1911:19, 2 July 2024 diff hist +236 Amivantamab →Legal status: nsclc in EU Tag: Visual edit
- 10:0110:01, 2 July 2024 diff hist +24 Eisai (company) infobox current Tag: Visual edit: Switched
- 09:5909:59, 2 July 2024 diff hist +69 Eisai (company) →Products: lecanemab Tag: Visual edit
- 09:5809:58, 2 July 2024 diff hist 0 Eisai (company) →History: lecanemab Tag: Visual edit
- 09:5709:57, 2 July 2024 diff hist +4 Eisai (company) →History: lecanemab Tag: Visual edit
- 09:5709:57, 2 July 2024 diff hist +338 Eisai (company) →History: lecanemab Tag: Visual edit
- 09:5609:56, 2 July 2024 diff hist +69 Eisai (company) →History: lecanemab Tag: Visual edit
- 09:5509:55, 2 July 2024 diff hist +323 Eisai (company) lecanemab Tag: Visual edit
- 09:5509:55, 2 July 2024 diff hist +126 Eisai (company) →History: lecanemab Tag: Visual edit
- 08:0008:00, 2 July 2024 diff hist −14 Eisai (company) infobox update Tag: Visual edit
- 07:5507:55, 2 July 2024 diff hist −48 Eisai (company) No edit summary Tag: Visual edit
- 07:5407:54, 2 July 2024 diff hist +166 Eisai (company) infobox update Tag: Visual edit
- 07:5107:51, 2 July 2024 diff hist −71 Eisai (company) infobox update Tag: Visual edit
- 07:4907:49, 2 July 2024 diff hist +23 Eisai (company) infobox update Tag: Visual edit
27 June 2024
- 23:4723:47, 27 June 2024 diff hist +311 Nokia Ref Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 23:4623:46, 27 June 2024 diff hist +58 Nokia Acquisition of Infinera Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 23:3223:32, 27 June 2024 diff hist +4 Infinera No edit summary Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 23:3123:31, 27 June 2024 diff hist +307 Infinera No edit summary Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 23:1923:19, 27 June 2024 diff hist +31 Infinera No edit summary Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 23:1623:16, 27 June 2024 diff hist +385 Infinera Acquired by Nokia Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 23:1423:14, 27 June 2024 diff hist +10 Infinera Acquired by Nokia Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
26 June 2024
- 20:0620:06, 26 June 2024 diff hist +206 Jarryd Hayne Charges dropped Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 20:0520:05, 26 June 2024 diff hist +157 Jarryd Hayne Charges dropped Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 20:0220:02, 26 June 2024 diff hist +311 Thomas Jordan (economist) ref current Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
- 20:0020:00, 26 June 2024 diff hist +110 Thomas Jordan (economist) Retirement Tags: Visual edit Mobile edit Mobile web edit Advanced mobile edit
25 June 2024
- 10:2910:29, 25 June 2024 diff hist +920 Ocrelizumab →History: updated infobox Tag: Visual edit
- 10:2410:24, 25 June 2024 diff hist +389 Ocrelizumab →History: SC infusion Tag: Visual edit
- 10:2010:20, 25 June 2024 diff hist +108 Ocrelizumab →History: SC infusion Tag: Visual edit
21 June 2024
- 11:1511:15, 21 June 2024 diff hist +21 Allbirds infobox update Tag: Visual edit
- 11:1311:13, 21 June 2024 diff hist +30 Allbirds infobox update Tag: Visual edit
- 11:1111:11, 21 June 2024 diff hist +54 Allbirds infobox update Tag: Visual edit
- 11:0311:03, 21 June 2024 diff hist +279 Allbirds Financial results Tag: Visual edit
- 10:5310:53, 21 June 2024 diff hist +510 MorphoSys Delisting from stock exchange current Tag: Visual edit
19 June 2024
- 15:3815:38, 19 June 2024 diff hist +264 Oracle Advertising shutdown current Tag: Visual edit
- 15:3715:37, 19 June 2024 diff hist +295 Oracle Advertising shutdown Tag: Visual edit
- 15:3615:36, 19 June 2024 diff hist +104 Oracle Advertising shutdown Tag: Visual edit
- 06:0806:08, 19 June 2024 diff hist +393 Pembrolizumab →History: Clinical Trial Tag: Visual edit
- 06:0706:07, 19 June 2024 diff hist +1,087 Pembrolizumab KEYNOTE-868/NRG-GY018
18 June 2024
- 08:2308:23, 18 June 2024 diff hist +29 Selpercatinib Adverse effects
- 08:2308:23, 18 June 2024 diff hist +375 Selpercatinib →Adverse effects
- 08:1408:14, 18 June 2024 diff hist +1,998 Selpercatinib FDA approval
- 08:1008:10, 18 June 2024 diff hist +351 Selpercatinib →History Tag: Visual edit: Switched
- 08:0808:08, 18 June 2024 diff hist +434 Selpercatinib →History: FDA approval Tag: Visual edit
- 08:0308:03, 18 June 2024 diff hist +429 Repotrectinib →TRIDENT-1 Tag: Visual edit
- 08:0208:02, 18 June 2024 diff hist −50 Repotrectinib Medical uses Tag: Visual edit
- 08:0008:00, 18 June 2024 diff hist +2,319 Repotrectinib Clinical trials Tag: Visual edit: Switched